The Cardiovascular Research Institute Maastricht (CARIM), part of the Maastricht University, has expertise in a wide range of areas, ranging from molecular biology to population-based studies.
Within EUTRAF they develop new diagnostic tools, aiming at a classification of AF based on biochemical serum markers, imaging techniques, and electrophysiological parameters.
Ulrich studied medicine at the Universities of Aachen, Glasgow and Valetta and currently holds a Chair in Cardiac Electrophysiology at the University Maastricht. He is Head of the CARIM Research Program Pathophysiology of Atrial Fibrillation, a staff member of the Department of Physiology at Maastricht University and Principal Investigator at the Cardiovascular Research Institute Maastricht.
Monika is Professor of Genetic Epidemiology at the University of Münster, Germany, and at the Cardiovascular Research Institute Maastricht, Netherlands. Her research focuses on the genetics of cardiovascular and inflammatory diseases. Her group has developed algorithms for the analysis of GWAS and pathway analysis and next generation sequencing approaches.
Harry JGM Crijns
Harry is professor and chair of the Department of Cardiology and board member of the Cardiovascular Research Institute Maastricht (CARIM) at Maastricht University Medical Center. His special interests include idiopathic AF, atherothrombotic mechanisms in AF progression, hybrid AF ablation and early rhythm control in high risk AF. His contributions include improved rate/rhythm control (RACE-trials, HATCH score), stroke prevention (CHA2DS2-VASc) and bleeding in AF (HAS-BLED).
Stef studied Knowledge Engineering at Maastricht University and is currently finishing his PhD in Systems Identification, focussing on estimation of sparse network interactions in an underdetermined setting. For the last 4 years he has been with the Department of Physiology, Maastricht University, where he has worked on complexity analysis of atrial fibrillation, based on both invasive and non-invasive measurement data, applied to the classification of AF progression and the prediction of AF treatment outcome.
Aaron is an Assistant Professor at the CARIM School for Cardiovascular Diseases and the Maastricht Centre for Systems Biology (MaCSBio), Maastricht University (the Netherlands). He completed his undergraduate studies at the University of California, Berkeley before pursuing a doctorate in genetic epidemiology at Erasmus University Medical Centre, Rotterdam (the Netherlands). He has published extensively in the field of genetics, focusing particularly on cardiovascular disease endophenotypes.
Elton received his BSc in Bio-medical Sciences from the University of Amsterdam in 2009 and his combined medical degree and MSc in Clinical Research from Maastricht University in 2013. After this, he started as a PhD-student in the group of professor Crijns at the Maastricht University Medical Center, focusing on biomarkers and cardiac imaging in atrial fibrillation.